TD Cowen Reiterates Buy on Eli Lilly, Maintains $1250 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.2%

Neg 0% Neu 88.2% Pos 0%

TD Cowen analyst Steve Scala reiterates Eli Lilly (NYSE:LLY) with a Buy and maintains $1250 price target.

Comments

No comments yet. Be the first!